Boston Scientific

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices for interventional medical specialties. The company says it has been a medical-technology leader for more than 45 years and has advanced less-invasive medicine by giving clinicians alternatives to surgery and other procedures that can be traumatic to the body. [1]

The business grew from the catheter-based medical-device company Medi-Tech; Boston Scientific identifies John Abele and Pete Nicholas as co-founders, and Nicholas's company biography describes the startup as having been built with fewer than 50 employees and early capital of a $500,000 loan plus $300,000 from partners. [2]

For 2025, Boston Scientific's products were organized into two reportable segments and five core businesses: Endoscopy, Urology and Neuromodulation in MedSurg, and Cardiology and Peripheral Interventions in Cardiovascular. The company develops endoscopic devices for gastrointestinal conditions, urological technologies for kidney stones, benign prostatic hyperplasia, prostate cancer and pelvic-health disorders, and implantable neuromodulation technologies for chronic pain and neurological conditions. [1] [3]

Its cardiovascular and electrophysiology portfolio includes technologies for heart and vascular conditions, cardiac-rhythm disorders and stroke-risk reduction, including the WATCHMAN left-atrial-appendage closure device. Boston Scientific reported $20.1 billion in fiscal-2025 sales, and its stated strategy is to strengthen category leadership, expand into high-growth adjacencies and extend global access to interventional technologies. [3] [4]